Could a common supplement ease stubborn pelvic pain?
NCT ID NCT07629505
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a daily CoQ10 supplement (Ralivia) can reduce pain and improve quality of life in men with chronic pelvic pain syndrome. One hundred men aged 18–50 will receive either the supplement or a placebo for 3 months. Researchers will measure changes in pain scores and other symptoms.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Coenzyme Q10 (CoQ10) supplement
- What this could lead to
- If it works, this could offer a simple, low-side-effect option to reduce pelvic pain in men with chronic prostatitis/chronic pelvic pain syndrome.
- What could go wrong
- This is an early-stage trial with only 100 participants, so results may not apply to everyone. The supplement may prove no better than placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC PELVIC PAIN SYNDROME (CPPS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
G.Gennimatas General Hospital
RECRUITINGThessaloniki, 54636, Greece
More trials for these conditions
Other studies related to the condition(s) this trial covers.